# A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

> **NCT07403188** · — · RECRUITING · sponsor: **Kyverna Therapeutics** · enrollment: 70 (estimated)

## Conditions studied

- Refractory Lupus Nephritis
- Myasthaenia Gravis
- Stiff Person Syndrome
- Rheumatoid Arthritis (RA)
- Multiple Sclerosis
- Dermatomyositis
- Systemic Sclerosis (SSc)

## Interventions

- **DRUG:** KYV-101

## Key facts

- **NCT ID:** NCT07403188
- **Lead sponsor:** Kyverna Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-24
- **Primary completion:** 2041-01
- **Final completion:** 2041-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07403188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07403188, "A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07403188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*